Hod Hasharon, Israel

Gilad Magnazi

This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Empress Medical, Inc., Rainbow Medical Ltd.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilad Magnazi. Retrieved from https://idiyas.com/inventor/gilad-magnazi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Gilad Magnazi

Introduction: Gilad Magnazi is a talented inventor hailing from Hod Hasharon, Israel. He has made significant contributions to the field of innovation with his creative ideas and problem-solving skills.

Latest Patents: Gilad Magnazi holds several patents in various industries, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his career, Gilad Magnazi has demonstrated a keen ability to identify gaps in the market and develop unique solutions to address them. His innovative approach has led to the successful commercialization of several products.

Collaborations: Gilad Magnazi has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that benefit society.

Conclusion: In conclusion, Gilad Magnazi is a visionary inventor who continues to push the boundaries of innovation. His passion for creating impactful solutions sets him apart in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…